Abstract:We thank Agilli et al for their interest in our article. They claimed that several factors, including diseases, drugs, and even the way samples are collected, can affect prealbumin serum levels. We agree with their comments. Protein energy malnutrition is a chronic and acute lean body protein loss that leads to a state of specific nutrient deficiency and is associated with a worse outcome during illness and may be reversed by conversion to an anabolic state. Serum prealbumin, a nutritional marker with a short half-life and a rapid synthesis rate, was affected by several factors including some diseases, inflammation, malnutrition, some drugs such as prednisone, and alcohol use. Our current study indicated that the incidence of major adverse events (MAEs) significantly increased in patients with lower levels of serum prealbumin. After adjustment for confounders, serum prealbumin levels emerged as one of the significant predictors of MAEs (death from any cause and further deterioration in renal function requiring chronic dialysis) in patients undergoing peripheral arterial angiography. In this cohort study, we excluded patients with multiple myeloma and the use of nonsteroidal anti-inflammatory drugs or corticosteroids. There was no significant difference between patients with and without MAEs in current drinking (P1⁄4 .620). This result was consistent with previous studies which evaluated prealbumin levels in patients after peripheral arterial angiography. Several studies suggested that malnutrition has a negative impact on the prognosis in patients with acute kidney injury (AKI) or heart failure. The meta-analysis provided evidence that hypoalbuminemia is a significant independent predictor of death following AKI development. According to Valdivieso et al, serum prealbumin levels <11 mg/dL were strongly associated with increased in-hospital mortality (hazard ratio, 2.10; 95% confidence interval, 1.08-4.08), compared to patients with the same AKI severity and treatment but with a serum prealbumin level 11 mg/dL. In addition, each increment of 5 mg/dL of serum prealbumin was associated with an adjusted 29% decrease in in-hospital morality. In a heart failure study, patients with discharge prealbumin 15 mg/dL had a higher 6-month morbidity and mortality. Similarly, in our previous study, a lower level of prealbumin was found to be significant in patients with hospital-acquired AKI who died within 28 days compared to those who survived >28 days (12.5 + 5.9 vs 16.4 + 6.9 mg/dL, P 1⁄4 .001). Furthermore, we are conducting another study to assess the impact of serum prealbumin level on prognosis of patients with AKI after coronary artery bypass graft operation. The results also show an independent association between lower prealbumin level and mortality. In conclusion, serum prealbumin could be an independent predictor of MAEs in AKI. Its serum levels should always be interpreted in light of the influencing factors, among which are concomitant disease, the inflammatory state, and liver function.

Relationship between serum prealbumin level and prognosis of community-acquired bacterial meningitis in adults: a retrospective cohort study

Predictive Value of Serum Albumin Level for the Prognosis of Severe Sepsis Without Exogenous Human Albumin Administration: A Prospective Cohort Study.

Neutrophil-to-Lymphocyte Ratio Improves the Accuracy and Sensitivity of Pneumonia Severity Index in Predicting 30-Day Mortality of CAP Patients

Serum Prealbumin Levels and Risks of Adverse Clinical Outcomes after Ischemic Stroke

Impact of Prealbumin Levels on Patients with Acute Kidney Injury

The prognostic value of serum albumin level in early stage of severe sepsis

Decreased prealbumin level is associated with increased risk for mortality in elderly hospitalized patients with COVID-19

Clinical Prognosis in Neonatal Bacterial Meningitis: The Role of Cerebrospinal Fluid Protein.

Association Between Serum Albumin and Hospital-Acquired Infections After Aneurysmal Subarachnoid Hemorrhage

Prognostic value of albumin-red cell distribution width score in patients with severe community-acquired pneumonia

Serum Prealbumin As an Effective Prognostic Indicator for Determining Clinical Status and Prognosis in Patients with Hemorrhagic Stroke

Serum prealbumin levels on admission as a prognostic marker in stroke patients treated with mechanical thrombectomy

Risk factors and prognosis of hypoalbuminemia in surgical septic patients.

Prealbumin as a Predictor of Prognosis in Patients With Coronavirus Disease 2019

Role of Prealbumin in Predicting the Prognosis of Severely and Critically Ill COVID-19 Patients.

The Prognostic Value of Serum Albumin Levels and Respiratory Rate for Community-Acquired Pneumonia: A Prospective, Multi-Center Study.

Serum prealbumin level as a predictor of in-hospital death of acute ischemic stroke patients

Preoperative Prealbumin Level As an Independent Predictor of Long-Term Prognosis after Curative Liver Resection of Hepatocellular Carcinoma: a Multicenter Study of 1,483 Patients

Preoperative Serum Albumin: a Promising Indicator of Early Mortality after Surgery for Infective Endocarditis

The relationship between fasting serum levels of prealbumin and the prognosis of SIRS in the elderly

Albumin/Procalcitonin Ratio Is a Sensitive Early Marker of Nosocomial Blood Stream Infection in Patients with Intra-Cerebral Hemorrhage.